InvestSMART

nanollose Limited (ASX: NC6) - Announcements

- Current share price for NC6 : $0.078

ASX company news and announcements for nanollose Limited (NC6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All nanollose Limited (NC6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than nanollose Limited (NC6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for nanollose Limited (NC6)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$32 Notice of General Meeting/Proxy Form 21 Jan 2025 1:07PM $0.017 $0.078 risen by 358.82%
$32 Application for quotation of securities - NC6 14 Jan 2025 5:40PM $0.019 $0.078 risen by 310.53%
$32 Change of Director's Interest Notice 14 Jan 2025 1:39PM $0.019 $0.078 risen by 310.53%
$32 Update - Proposed issue of securities - NC6 14 Jan 2025 9:08AM $0.019 $0.078 risen by 310.53%
$32 Entitlement Issue Prospectus 14 Jan 2025 8:15AM $0.019 $0.078 risen by 310.53%
$32 Notification of cessation of securities - NC6 13 Jan 2025 8:25PM $0.019 $0.078 risen by 310.53%
$32 Ceasing to be a substantial holder 3 Jan 2025 8:21AM $0.019 $0.078 risen by 310.53%
$32 Becoming a substantial holder 24 Dec 2024 11:51AM $0.019 $0.078 risen by 310.53%
$32 Application for quotation of securities - NC6 23 Dec 2024 10:20AM $0.019 $0.078 risen by 310.53%
$32 Becoming a substantial holder 20 Dec 2024 7:56PM $0.019 $0.078 risen by 310.53%
$32 Change of Director's Interest Notice 13 Dec 2024 7:28PM $0.019 $0.078 risen by 310.53%
$32 Notification of cessation of securities - NC6 13 Dec 2024 7:19PM $0.019 $0.078 risen by 310.53%
$32 Proposed issue of securities - NC6 13 Dec 2024 9:57AM $0.030 $0.078 risen by 160%
$32 Strategic $2.1M Capital Raising 13 Dec 2024 9:57AM $0.030 $0.078 risen by 160%
$32 Notification of cessation of securities - NC6 9 Dec 2024 4:57PM $0.029 $0.078 risen by 168.97%
$32 Change of Director's Interest Notice 6 Dec 2024 7:01PM $0.031 $0.078 risen by 151.61%
$32 Results of Meeting 15 Nov 2024 8:20AM $0.017 $0.078 risen by 358.82%
$32 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 9:03AM $0.017 $0.078 risen by 358.82%
$32 Proposed issue of securities - NC6 11 Oct 2024 4:15PM $0.019 $0.078 risen by 310.53%
$32 Notice of Annual General Meeting/Proxy Form 11 Oct 2024 4:14PM $0.019 $0.078 risen by 310.53%
$32 Notification of cessation of securities - NC6 17 Sep 2024 4:51PM $0.019 $0.078 risen by 310.53%
$32 FIRST NUFOLIUM FIBRE SHIPMENT FOR PRODUCT TESTING 6 Sep 2024 8:40AM $0.020 $0.078 risen by 290%
$32 Appendix 4G & Corporate Governance Statement 29 Aug 2024 7:50AM $0.021 $0.078 risen by 271.43%
$32 Annual Report & Appendix 4E 29 Aug 2024 7:50AM $0.021 $0.078 risen by 271.43%
$32 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 4:58PM $0.019 $0.078 risen by 310.53%

101 - 125 of 398 results

Page 5 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.